Seniors may drop antidepressants because of side effects from other drugs, study finds

Share this article:

Many American seniors begin taking antidepressants while on medications with contraindications, according to a new study. Because of side effects, many then stop taking the antidepressants.

A study conducted by Thompson Reuters, the University of Southern California and drugmaker Sanofi Aventis found that among American seniors who were first-time antidepressant takers, more than half started taking them while on other contraindicated drugs. Due to resulting side effects, one quarter of them discontinued the antidepressant.

The investigators used information from a database of Medicare claims, where they discovered that 39,000 patients started taking antidepressants between 2001 and 2006. More than 25% of these patients were taking antidepressants in addition to other medications that could cause major drug interactions. Thirty-six percent of these patients were prescribed antidepressants while taking other medications that could cause moderate reactions. A total of 45% of seniors who reported side effects refilled their prescriptions, according to the study whose results were published online in The American Journal of General Psychiatry.

Share this article:

More in News

CMS expands therapy payment research

The government is expanding its research into alternative therapy payments, to consider more holistic changes to the way Medicare reimburses skilled nursing facilities, the Centers for Medicare & Medicaid Services announced Tuesday.

CDC tightens Ebola guidelines for healthcare workers

The Centers for Disease Control and Prevention has issued more stringent guidelines for how healthcare workers should interact with Ebola patients, following an outcry from nurses and other professionals.

Nonprofit providers face alarming market forces, must rally, LeadingAge chairman says

Nonprofit providers face alarming market forces, must rally, ...

Nonprofit long-term care providers must work together to address alarming trends, or their market share could plummet and the sector as a whole could falter, LeadingAge Chairman David Gehm told ...